Evidence map›Paper›PMID 39735282›Full record

ArticleHealth care science2024

A novel ensemble ARIMA-LSTM approach for evaluating COVID-19 cases and future outbreak preparedness.

Somit Jain, Shobhit Agrawal, Eshaan Mohapatra, Kathiravan Srinivasan

Abstract read
In one paragraph

Article in Health care science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Somit JainSchool of Computer Science and Engineering, Vellore Institute of Technology Vellore India.
Shobhit AgrawalSchool of Computer Science and Engineering, Vellore Institute of Technology Vellore India.
Eshaan MohapatraSchool of Computer Science and Engineering, Vellore Institute of Technology Vellore India.
Kathiravan SrinivasanSchool of Computer Science and Engineering, Vellore Institute of Technology Vellore India.ORCID 0000-0002-9352-0237

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The global impact of the highly contagious COVID-19 virus has created unprecedented challenges, significantly impacting public health and economies worldwide. This research article conducts a time series analysis of COVID-19 data across various countries, including India, Brazil, Russia, and the United States, with a particular emphasis on total confirmed cases. Methods: The proposed approach combines auto-regressive integrated moving average (ARIMA)'s ability to capture linear trends and seasonality with long short-term memory (LSTM) networks, which are designed to learn complex nonlinear dependencies in the data. This hybrid approach surpasses both individual models and existing ARIMA-artificial neural network (ANN) hybrids, which often struggle with highly nonlinear time series like COVID-19 data. By integrating ARIMA and LSTM, the model aims to achieve superior forecasting accuracy compared to baseline models, including ARIMA, Gated Recurrent Unit (GRU), LSTM, and Prophet. Results: The hybrid ARIMA-LSTM model outperformed the benchmark models, achieving a mean absolute percentage error (MAPE) score of 2.4%. Among the benchmark models, GRU performed the best with a MAPE score of 2.9%, followed by LSTM with a score of 3.6%. Conclusions: The proposed ARIMA-LSTM hybrid model outperforms ARIMA, GRU, LSTM, Prophet, and the ARIMA-ANN hybrid model when evaluating using metrics like MAPE, symmetric mean absolute percentage error, and median absolute percentage error across all countries analyzed. These findings have the potential to significantly improve preparedness and response efforts by public health authorities, allowing for more efficient resource allocation and targeted interventions.

Indexed as

ANNARIMACOVID‐19GRULSTMprophetproposed modeltime series

Identifiers

PMID39735282
PMCPMC11671211

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.